Rotec 50™
[Diclofenac Sodium + Misoprostol]
Active Ingredients
Diclofenac Sodium 50 mg
Misoprostol 200 mcg
Description / Properties
Each tablet consists of an enteric-coated core containing 50 mg diclofenac sodium surrounded by an outer mantle containing 200 mcg Misoprostol.
Diclofenac component of Rotec 50™ provides better anti-inflammatory action than conventional NSAIDs and COX-2 Inhibitors.
Misoprostol component of Rotec 50™ is the only agent approved by FDA for preventing NSAID induced ulcers.
Due to established efficacy and safety of Diclofenac and Misoprostol, Rotec 50™ can be given safely to a wide variety of patients including high-risk patients.
Due to built-in GI mucosal protection, the cost of concomitant acid suppressive therapies and cost of NSAID induced GI hospitalization is reduced significantly.
Patient compliance is improved with just I tablet BID.
Indications
For acute and chronic treatment of the signs and symptoms of:
Osteoarthritis
Rheumatoid arthritis
Contraindication
Pregnancy, hypersensitivity, lactation, patients with active gastrointestinal bleeding
Drug Interactions
Concomitant treatment with aspirin, anti-coagulants, potassium sparing diuretics, lithium, digoxin, methotrexate, magnesium containing antacids.
Side Effects
Abdominal pain, diarrhea, nausea/vomiting, headache and dermatological reactions. Diarrhea is usually mild to moderate and transient and can be minimized by taking Rotec 50™ with food and by avoiding magnesium containing antacid.
Warning and Precautions
In patients receiving long term NSAID should be monitored as a precautionary measure (e.g. renal, hepatic function and blood counts). The safety and efficacy of Rotec 50™ in children under the age of 18 years have not been established.
Dosage
One tablet to be taken with food two or three times daily . Tablets should be swallowed whole not to chewed, crushed or dissolved.
Presentations Available
Blister pack of 20 Tablets
MORE PRODUCTS >
|
|